Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Smruthi OrganicsBOM:540686 -2.31%68 PB Ratio is 1.81 as of Jul. 16, 2026, which is 6% below its 10-year median of 1.92. GuruFocus rates BOM:540686 with a GF Score™ of 68/100 and a GF Value™ of ₹107.46 (Fairly Valued). The stock has 4 warning signs investors should review. Among 922 Drug Manufacturers companies, Smruthi Organics ranks better than 52.39% on this metric.
The PB Ratio, or Price-to-Book ratio, or Price/Book, is a financial ratio used to compare a company's market price to its Book Value per Share. As of today (2026-07-16), Smruthi Organics's share price is ₹116.05. Smruthi Organics's Book Value per Share for the quarter that ended in Mar. 2026 was ₹64.23. Hence, Smruthi Organics's PB Ratio of today is 1.81.
The historical rank and industry rank for Smruthi Organics's PB Ratio or its related term are showing as below:
BOM:540686'
s PB Ratio Range Over the Past 10 Years
Min: 0.67 Med: 1.92 Max: 6.24
Current: 1.81
During the past 13 years, Smruthi Organics's highest PB Ratio was 6.24. The lowest was 0.67. And the median was 1.92.
BOM:540686's PB Ratio is ranked better than 52.39% of 922
companies
in the Drug Manufacturers industry
Industry Median: 1.955
vs BOM:540686: 1.81
During the past 12 months, Smruthi Organics's average Book Value Per Share Growth Rate was 2.60% per year.
During the past 3 years, the average Book Value Per Share Growth Rate was 2.60% per year.
During the past 5 years, the average Book Value Per Share Growth Rate was 3.50% per year.
During the past 10 years, the average Book Value Per Share Growth Rate was 11.40% per year.
During the past 13 years, the highest 3-Year average Book Value Per Share Growth Rate of Smruthi Organics was 40.70% per year. The lowest was -10.50% per year. And the median was 5.80% per year.
Back to Basics: PB Ratio
Smruthi Organics (BOM:540686) PB Ratio Explanation
The PB Ratio works the best for the businesses that earn most of their profit from their assets, e.g. banks and insurance companies.
Be Aware
Some businesses have very light assets, such as software companies or insurance agencies. The PB Ratio does not work well for these companies. Some companies even have negative equity, so the PB Ratio cannot be applied to them.
Smruthi Organics PB Ratio Related Terms
Smruthi Organics PB Ratio Historical Data
* Premium members only.
The historical data trend for Smruthi Organics's PB Ratio can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Drug Manufacturers - Specialty & Generic subindustry, Smruthi Organics's PB Ratio, along with its competitors' market caps and PB Ratio data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Smruthi Organics PB Ratio vs Drug Manufacturers Industry
For the Drug Manufacturers industry and Healthcare sector, Smruthi Organics's PB Ratio distribution charts can be found below:
* The bar in red indicates where Smruthi Organics's PB Ratio falls into.
The PB Ratio, or Price-to-Book ratio, or Price/Book, is a financial ratio used to compare a company's market price to its Book Value per Share. It is a ratio widely used to value stocks.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
It can also be calculated from the numbers for the whole company:
A closely related ratio is called Price-to-Tangible-Book. The difference between Price-to-Tangible-Book and PB Ratio is that book value other than intangibles are used in the calculation.
Smruthi Organics (BOM:540686) has a PB Ratio of 1.81 as of Jul. 16, 2026. Price-to-Book ratio is the ratio of share price to a company's book value per share. View historical data on Smruthi Organics and its competitors. This is near median its historical median of 1.92. Over the past decade, Smruthi Organics' PB Ratio has ranged from 0.67 to 6.24. According to the industry distribution chart, Smruthi Organics ranks #439 out of 922 companies in the Drug Manufacturers industry, placing it in the top 47.6%.
Is Smruthi Organics' PB Ratio too high?
Smruthi Organics' current PB Ratio of 1.81 is near median its 10-year median of 1.92. Over the past 10 years, this metric has ranged from a low of 0.67 to a high of 6.24. The Drug Manufacturers industry median PB Ratio is 1.96. Smruthi Organics' value of 1.81 is 7.4% below this industry median. Based on the distribution chart, Smruthi Organics ranks #439 out of 922 companies in the Drug Manufacturers industry, which is above the industry midpoint. Overall, Smruthi Organics has a GF Score™ of 68/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does Smruthi Organics' PB Ratio compare to ZTS and UTHR?
According to the Drug Manufacturers industry distribution chart, Smruthi Organics ranks #439 out of 922 companies for PB Ratio. This puts Smruthi Organics in the upper half of its industry. The industry median PB Ratio is 1.96. Smruthi Organics' value of 1.81 is 7.4% below this benchmark. Historically, Smruthi Organics' own PB Ratio has ranged from 0.67 to 6.24 over the past decade. While the company's 10-year median is 1.92 vs. the industry median of 1.96, Smruthi Organics has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good PB Ratio for a Drug Manufacturers company?
The median PB Ratio among Drug Manufacturers companies is 1.96, based on 922 companies in the industry. Companies in the top quartile (top 25%) have a PB Ratio significantly above this median, while those in the bottom quartile fall well below. However, PB Ratio should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Smruthi Organics's current PB Ratio of 1.81 is 7.4% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high PB Ratio mean?
A high PB Ratio can signal that a stock is expensive relative to its fundamentals. Price-to-Book ratio is the ratio of share price to a company's book value per share. View historical data on Smruthi Organics and its competitors. For the Drug Manufacturers industry, the median PB Ratio is 1.96 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Smruthi Organics's current PB Ratio is 1.81, which is near median its own 10-year median of 1.92. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Smruthi Organics stock overvalued right now?
Based on GuruFocus' analysis, Smruthi Organics (BOM:540686) is currently considered Fairly Valued. The stock's GF Value™ is ₹107.46, compared to a current price of ₹116.05 — trading 8% above its estimated fair value. The current PB Ratio is 1.81, which is near median its 10-year median of 1.92 and 7.4% below the Drug Manufacturers industry median of 1.96. Smruthi Organics' overall GF Score™ is 68/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is PB Ratio calculated?
PB Ratio is calculated from a company's financial statements. For Smruthi Organics (BOM:540686), the current PB Ratio is 1.81 as of Jul. 16, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Smruthi Organics (BOM:540686) Overvalued in 2026?
Based on GuruFocus' analysis, Smruthi Organics stock appears to be overvalued.
The current stock price of ₹116.05 is trading 8% above its estimated GF Value™ of ₹107.46.
GuruFocus considers Smruthi Organics to be Fairly Valued.
Key valuation signals for BOM:540686:
PB Ratio: 1.81 (near median its 10-year median of 1.92)
GF Value™: ₹107.46 vs. price of ₹116.05 (8% above fair value)
Industry Position: 7.4% below the Drug Manufacturers median (#439 of 922)
No single metric tells the full story. See the BOM:540686 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Smruthi Organics Ltd is engaged in the manufacture of bulk drugs and drug intermediates (API Products). The product portfolio includes Amlodipine Besilate, Amlodipine Base, S-Amlodipine Besilate, S-Amlodipine Base, Norfloxacin, Metformin HCI, Diloxanide Furoate, Phthaloyl Amlodipine, Pantoprazole Sodium, Pefloxacin Mesylate Dihydrate, Telmisartan, Losartan Potassium, and many more. It has two reportable business segments: Bulk Drugs and Drugs Intermediates (API), and Formulation. It generates the majority of its revenue from the Bulk Drugs and Drugs Intermediates (API) segment. Geographically, the company generates maximum revenue from outside India through exports, and the rest from its business within India.
68GF Score
Get the complete analysis for BOM:540686
PB Ratio is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
BOM:540686 has been successfully added to your 
